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Abstract
Background: Nociceptive responses to noxious stimuli are initiated at peripheral nociceptor terminals. Ion
channels play a vital role in pain signal initiation and conduction. Activation of KATP channels has been implicated
in mediating the analgesic effects of agents such as morphine. However, systematic studies regarding the effects
of KATP activators on nociception and neuronal excitability are scarce.
Results: In this study, we describe the antagonistic effects of KATP activators pinacidil and diazoxide on nocifensive
behavior induced by bradykinin (BK), thermo and mechanical stimuli, and the bradykinin-induced hyperexcitability
of DRG neurons. We also found that KATP activators can moderately activate KATP in DRG neurons. Because the
effects of KATP activators can be reversed by the KATP blocker glyburide, direct activation of KATP is most likely the
underlying mechanism.
Conclusion: This systematic study clearly demonstrates that activation of KATP could have significant modulatory
effects on the excitability of sensory neurons and thus on sensory behaviors, such as nociception. KATP activators
can be evaluated clinically for the treatment of pain symptoms.
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Background
Ion channels play a vital role in pain signal initiation
and conduction [1]. For example, activation of TRPV1
following a heat stimulus generates inward currents in
the nociceptor peripheral terminal and results in action
potentials in the nociceptor axon, leading to pain sensa-
tion [2-5]. The TRP channel family and voltage gated
sodium channels are among the most intensively studied
ion channels in pain signaling. Until recently, less atten-
tion has been paid to the role of potassium (K
+)c h a n -
nels in pain [6-17]. K
+ channels play an essential role in
setting the resting membrane potential and in control-
ling the excitability of neurons. Thus, K
+ channels
represent potentially attractive peripheral targets for the
treatment of pain. One K
+ channel that is known to reg-
ulate excitability in a variety of central and peripheral
neurons is the M channel [18,19]. Activation of the M
channel by retigabine inhibits responses to the intrapaw
application of carrageenan [7] and bradykinin [6] in rat
nociceptive behavioral studies. The M channel blocker
XE991 evokes spontaneous pain in rats [12,20].
Another family of K
+ channels that has recently been
indicated in pain responses is the ATP-sensitive potassium
channel (KATP) family. These channels are widely
expressed in central neurons, wherein they regulate mem-
brane excitability and neurotransmitter release, and they
provide neuroprotection [21,22]. It has been suggested
that KATP may mediate the analgesic effects of morphine
[23], clonidine [24] and 5-HT1 agonists [25] because the
antinociceptive effects of these agents could be reversed by
pretreatment with selective KATP antagonists but not other
potassium channels blockers [26]. Studies indicate that the
nitric oxide (NO) pathway mediates the morphine activa-
tion of KATP [16,27]. Indeed, NO donors produce periph-
eral antinociceptive effects in inflammatory pain [27,28]
and directly activate KATP in rat DRG neurons [14].
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has only recently been confirmed [8,13-15,17]. However,
in vitro studies on DRG neurons demonstrate whole-cell
KATP currents that either show unusual rectification
properties or are expressed in only a subpopulation of
the neurons [8,11]. Activation or inhibition of KATP has
only minor effects on the resting membrane potential of
the subpopulation of neurons [11,15]. It has been sug-
gested [13,15] that KATP may play a major role in large
diameter DRG neuron-mediated neuropathic pain.
There is also evidence suggesting that the anti-nocicep-
tive effects of KATP activators may stimulate mechan-
isms that produce anti-nociception through opioid
receptor activation [29,30]. However, studies on the
effects of direct KATP activation on peripheral antinoci-
ception are scarce [31-33].
The primary purpose of the present study is to estab-
lish the effects of direct activation of KATP on pain sen-
sation and the excitability of sensory neurons. We
performed experiments testing the effects of two KATP
activators, diazoxide and pinacidil, on pain behaviors
induced by bradykinin and thermal and mechanical sti-
muli. We also studied the effects of KATP activators on
the excitability and whole-cell currents of DRG neurons.
The results show that activation of KATP antagonizes
the rat nociceptive behavior induced by all tested stimuli
and dampens the hyperexcitability of DRG neurons
induced by bradykinin.
Results
The KATP channel activators antagonize bradykinin-
induced spontaneous pain behavior
We tested effects of the KATP activators on BK-induced
nocifensive behavior in rats. We evaluated nocifensive
behavior (time spent in licking, biting and flinching the
affected paw) following the hind paw injection of 50 μl
of saline containing the relevant compounds. Consistent
with our earlier study [20], intraplantar injection of BK
(200 μM) into the rat hind paw produced strong noci-
fensive behavior (quantified within first 30 min after
injection; BK, 121 ± 5.7 s, n = 8), which was not
observed in rats injected with solvent (0.5% DMSO in
saline. 11 ± 7.7 s, n = 8), with the KATP channel activa-
tors diazoxide (Dia, 100 μM, 3.8 ± 3.2 s, n = 9) and
pinacidil (Pin, 10 μM, 3.6 ± 2.6 s, n = 9), or with the
channel blocker glyburide (Gly, 10 μM, 11 ± 8.1 s, n =
9) (Figure 1A). Co-application of the KATP activators
with BK (following a pre-application of the activators;
see Methods for details.) greatly reduced the BK-
induced nociceptive behavior. As demonstrated in Fig-
ure 1A, diazoxide (100 μM) and pinacidil (10 μM)
reduced the BK-induced pain behavior by approximately
h a l f( D i a+B K ,5 9±8 . 0s ,n=8 ;P i n+B K ,4 9±5 . 0s ,
n = 8). The solvent control for diazoxide and pinacidil
did not affect BK-induced nociceptive effects (DMSO,
0.5%, 120 ± 7.3 s, n = 8; Figure 1A). To test if the anti-
nociceptive effects of the KATP activators could be
relieved by blocking KATP,g l y b u r i d e( 1 0μM) was
applied together with diazoxide or pinacidil. Indeed, gly-
buride greatly reduced the antinociceptive effects of
diazoxide and pinacidil (Figure 1A, Gly + Dia + BK, 104
±1 2 . 4s ,n=8 ;G l y+P i n+B K ,8 5±1 0 . 8s ,n=8 ) .
The experiments presented in Figure 1A were repeated
at least three times, and similar qualitative conclusions
were reached. Thus activation of KATP effectively
reduced BK-induced spontaneous pain behavior.
To confirm that the observed effects of the KATP acti-
vators were the results of direct actions on the nocicep-
tors rather than some indirect systemic effects of the
KATP activators, two extra control experiments were
performed. First, to exclude the possibility that the
decreased behavioral responses to BK was the result of a
systemic effect of the KATP activators (i.e. lowered blood
pressure), pinacidil was injected into the contralateral
paw (left) of the paw (right) injected with BK, and the
BK-induced behavioral responses were compared with
those when pinacidil was co-injected with BK in the
same paw (right). As shown in Figure S1A (Additional
file 1, Figure S1A), contralateral paw injection of pinaci-
dil did not affect BK-induced behavioral responses. The
second control experiments were performed to exclude
the possibility that the observed anti-nociceptive effects
of KATP activators were the results of the vasodilatation,
since the primary effect of pinacidil is a vasodilator. The
increase in arteriolar blood flow may potentially affect
the behavioral outcome. Although apparent vasodilata-
tion was not observed upon injection of KATP activators
visually, a control vasodilator, phentolamine, was used
as a control vasodilator to be tested for its effect on
nociceptive behavior. Clearly, as shown in Figure S1B
(Additional file 1, Figure S1B), phentolamine did not
affect the BK-induced behavioral responses.
The KATP channel activators antagonize thermal pain
behavior
We used the Hargreaves test [34], in which the paw is
heated by a radiant heat source, to study the effects of
the KATP activators on thermal nociception. In this case,
the latency to paw licking or withdrawal was measured
in the absence or presence of KATP activators and block-
ers. Thermal nociceptive behavior was studied 8 min
after the intraplantar injection of 50 μl of one of the fol-
lowing solutions: solvent alone, the KATP channel activa-
tors, and the activators plus blockers. As demonstrated
in Figure 1B, compared with the solvent control, both
diazoxide (100 μM) and pinacidil (10 μM) significantly
increased the time latencies for thermal nociceptive
b e h a v i o r( S o l v e n t ,2 3±2 . 8s ,n=1 2 ;P i n ,3 6±2 . 9s ,n
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Figure 1 KATP openers attenuate nocifensive behavior induced by BK, thermal and mechanical stimuli. (A) Effects of KATP openers on BK-
induced nocifensive behavior. For first series of the experiment, solvent (DMSO, 0.5%), BK (200 μM), KATP channel openers pinacidil (Pin, 10 μM),
or diazoxide (Dia, 100 μM), or KATP channel blocker glyburide (Gly, 10 μM), were dissolved in saline and injected into the rat hind paw of
different rats in a volume of 50 μl in each case. In the second series of the experiments, Pin, Dia, mixture of Pin + Gly, mixture of Dia + Gly or
solvent was injected 5 min before the injection of BK plus the mixture (second injection was done into the same site). The time the animals
spent licking, biting and flinching the injected paw during 30 min was recorded and shown. n = 8 for each group. **p < 0.01, compared with
solvent group; #p < 0.05, compared with BK group; +p < 0.05, compared with BK + Dia or BK + Pin groups. (B) Effects of KATP channel openers
on thermal-induced nocifensive behavior. Pin, Dia, mixture of Gly + Pin, mixture of Gly + Dia or solvent was injected into the rat hind paw in 50
μl. 8 min later, the injected hind paw was subjected to radiant heat from underneath the glass floor with a high-intensity lamp bulb, and paw
withdrawal latency was measured and presented. n = 10-13. *p < 0.05, compared with solvent group; #p < 0.05, compared with Pin group. (C)
Effects of KATP channel openers on mechanical-induced nocifensive behavior. Pin, Dia, mixture of Gly + Pin, mixture of Gly + Dia or solvent was
injected into the rat hind paw in 50 μl. 8 min later, paw withdrawal thresholds (g) were measured using calibrated von Frey filaments applied to
the plantar surface of the injected paw. n = 11-12. *p < 0.05, compared with solvent group; #p < 0.05, compared with Pin or Dia groups.
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Page 3 of 12= 12; Dia 35 ± 3.0 s, n = 13). Pre-injection of glyburide
together with the KATP activators reversed the anti-ther-
mal nociceptive effects of the KATP channel activators,
although the effects of glyburide on diazoxide did not
reach statistical significance (Figure 1B, Gly + Pin, 26 ±
1.7 s, n = 12; Gly + Dia, 31 ± 4.1 s, n = 10). Glyburide
alone did not affect thermal nociceptive behavior (26 ±
2.5 s, n = 13). These results show that activation of
KATP can reduce the sensitivity to noxious heat stimuli.
The KATP channel activators antagonize the nociceptive
response to mechanical stimuli
We used von Frey filaments to test withdrawal thresh-
olds for mechanical stimuli applied to the hind paw of
rats. The solvent control or KATP activators (50 μl) were
injected into the plantar of the rat hind paw, and the
response to the mechanical stimuli was measured 8 min
later. The KATP activators significantly increased the
threshold for nocifensive withdrawal of the hind paw in
response to mechanical stimuli (Figure 1C, Solvent, 23 ±
3.8 s, n = 12; Pin, 41 ± 6.5 s, n = 10; Dia, 44 ± 5.8 s, n
= 12). Pre-injection of glyburide together with the KATP
activators reversed the effects of the KATP channel acti-
vators (Figure 1C, Gly + Pin, 26 ± 4.9 s, n = 12; Dia +
G l i b ,2 3±4 . 2s ,n=1 1 ) .G l y b u r i d ea l o n ed i dn o ta f f e c t
mechanical nociceptive behavior (25 ± 5.9 s, n = 11).
These results show that activation of KATP can reduce
the sensitivity to noxious mechanical stimuli.
Effects of the KATP activators on the increased excitability
of DRG neurons induced by BK
In our earlier study, we showed that BK can depolarize
the membrane potential and increase the firing fre-
quency of DRG neurons by inhibiting M-type K
+ cur-
rents and activating Ca
2+ activated Cl
- currents [20]. We
examined whether activation of KATP could affect the
increased excitability of DRG neurons induced by BK.
In control neurons under current-clamp conditions
(amphotericin B perforated patch recording), the injec-
tion of 300 pA depolarizing current elicited either one
action potential (AP; Figure 2A) or multiple APs (Figure
2 B )i nat o t a lo f4 9r e c o r d i n g sf r o mD R Gn e u r o n s .
There were also 8 neurons that did not produce any fir-
ing upon injection of 300 pA (larger depolarization cur-
rents were applied on these neurons). In 35 of the 57
neurons, the AP firing frequency was markedly
increased by 200 nM BK from 3.7 ± 0.85 AP/s to 8.2 ±
1.43 AP/s (n = 35, p < 0.01; Figure 2C). Pinacidil (10
μM) reversed the BK-induced increased firing (Figure
2C, BK + Pin, AP/s 2.75 ± 0.76, n = 35, p < 0.01). BK
also substantially depolarized the resting membrane
potential (RMP) from -50.2 ± 3.32 mV to -42.8 ± 3.49
mV (Figure 2D, n = 35, p < 0.05), and this effect was
reversed by pinacidil (Figure 2D, RMP -52.9 ± 3.35 mV,
n = 35, p < 0.05).
A subset of DRG neurons responded to BK stimula-
tion differently from those neurons shown in Figure 2.
In these neurons, as shown in Figure 3A, the application
of BK did not increase the firing frequency of the neu-
rons, but depolarized the membrane substantially. In
fact, the membrane was completely depolarized in these
neurons (Figure 3B, RMP -47.5 ± 2.81, n = 7 for control,
-3.1 ± 2.94, n = 7 for BK, p < 0.05). Pinacidil, when
applied in the presence of BK, totally reversed this BK-
induced depolarization (Figure 3B, RMP -44.3 ± 3.28 n
= 7 for BK + Pin, p < 0.05 compared with BK). Taken
together, the above results suggest that activation of
KATP could counteract the BK-induced hyperexcitability
of DRG neurons.
Effects of KATP activators and blockers on currents
recorded from rat DRG neurons
We then designed a voltage protocol to test the effects
of KATP activators and blockers on currents recorded
from adult rat DRG neurons. The voltage protocol used
is shown at the top of Figure 4A. The protocol was
designed to serve three major purposes: 1) to record
both KATP and M-type K
+ currents because M-type cur-
rents are believed to be the major K
+ currents that con-
trol general neuronal excitability [18,19] and particularly
DRG excitability [3,20]; 2) to record currents around the
resting membrane potential level (-50~ -60 mV) and at
the potential for an optimal manifestation of KATP cur-
rents (-140 mV); 3) to minimize the activation of other
depolarization-activated K
+ currents. Thus, M-type cur-
rents can be observed at -20 mV (activating currents)
and at -50 mV (deactivating tail currents), and KATP
currents can be observed at -140 mV as well as at
around -60 mV.
The currents recorded using the protocol described
a b o v ea r es h o w ni nF i g u r e4 .T h ed o t t e dl i n ei nF i g u r e
4A indicates the zero current level. Substantial basal
outward currents were observed at -20 mV, whereas
small inward currents were seen at -140 mV. Small slow
deactivating tail currents were observed when the mem-
brane potentials were step changed from -20 mV to -50
mV or -60 mV, and these currents eventually reached
the zero current level when the membrane potential was
at -60 mV (Figure 4A, control). These characteristics of
the basal currents are consistent with the presence of
outwardly rectifying K
+ currents (K
+ reversal potential is
calculated to be around -100 mV). The resting mem-
brane potential for this cell should be around -60 mV.
Pinacidil (10 μM) evoked a small increase of both the
outward currents at -20 mV and the inward currents at
-140 mV, and these effects were blocked by glyburide
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Figure 2 KATP opener reverses BK-induced hyperexcitability of DRG neurons. Current clamp recordings from rat DRG neurons; action
potentials were elicited by 300 pA current injection for 500 ms period. Either one (A) or multiple (B) action potentials were induced by the
depolarization, and the firing frequency was increased by BK (200 nM), which was reversed by pinacidil (Pin, 10 μM). (C) Numbers of action
potentials/s (AP) in the absence or presence of BK, pinacidil and BK plus pinacidil. n = 35, **p < 0.01. (D) Resting membrane potentials (RMP) of
DRG neurons and the effects of BK, pinacidil and BK plus pinacidil. n = 35, *p < 0.05.
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Page 5 of 12(10 μM). Neither pinacidil nor glyburide significantly
affected the currents at -50 mV or -60 mV (Figure 4A).
Figure 4B shows the time course of the currents
recorded at -20 mV and - 140 mV. Pinacidil and diazox-
ide slightly increased the inward current at -140 mV and
the outward currents at -20 mV, and these effects were
also reversed by glyburide, consisted with the increased
currents being KATP currents. To demonstrate the effect
of pinacidil and diazoxide more clearly, the current
traces from -140 mV were rescaled (Figure 4B, squared
box). Capsaicin, an agonist of the TRPV channel, was
applied at the end of the experiments and usually
evoked a large inward current at both -140 mV and -20
mV (Figure 4B).
The effects of pinacidil and diazoxide are summarized
in Figure 5. Figure 5A shows normalized currents
recorded at -140 mV before and after the application of
KATP channel activators alone or with glyburide.
Although both pinacidil and diazoxide increased the
inward currents at -140 mV by ~10% and the effects
were inhibited by glyburide, the difference did not reach
statistical significance (P > 0.05).
The basal currents were large compared with the
increased currents by KATP activators (Figure 4). Because
we do not know the source of these currents, including
these currents in the analysis of the effects of the KATP
activators and blocker (Figure 5A) could underestimate
the effects of the KATP activators. In addition, not all neu-
rons responded to the KATP activators, but these neurons
were included in the analysis shown in Figure 5A. To
better assess the actions of the KATP activators and
blocker, we re-analyzed the data, and the results are
shown in Figure 5B. In this case, only neurons that had a
visible response to the KATP activators (31 out of 60) and
blocker (6 out of 60) were included for analysis. Further-
more, the basal current levels were taken as a zero cur-
rent level, and only the currents increased or reduced by
the KATP activators and blocker were used for the analy-
sis. Thus, the basal currents were excluded from the ana-
lysis. Figure 5B shows that both pinacidil (n = 25) and
diazoxide (n = 16) significantly activated currents
recorded at -140 mV, and these effects were abolished by
glyburide. Of the 60 neurons tested, 23 did not respond
to the KATP activators or blocker and were not included
in the analysis shown in Figure 5B. These results suggest
that the KATP activators activate the KATP currents in a
subpopulation of DRG neurons.
Discussion
In this study, we described the antagonistic effects of the
KATP activators, pinacidil and diazoxide, on nocifensive
behavior induced by bradykinin, thermal and mechanical
stimuli and the bradykinin-induced hyperexcitability of
DRG neurons. We also found that the KATP activators
can moderately activate KATP in DRG neurons. Because
the effects of the KATP activators could be reversed by
the KATP blocker glyburide, the direct activation of KATP
is the most likely the underlying mechanism. This sys-
tematic study clearly demonstrates that activation of
KATP could have significant modulatory effects on excit-
ability of the sensory neurons and thus on sensory beha-
vior, such as nociception.
Many studies have provided evidence suggesting that
analgesic agents, such as opioid and non-opioid receptor
0
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Figure 3 KATP opener reverses BK-induced marked
depolarization. (A) Representative recordings showing BK-induced
marked membrane depolarization without changes in action
potential number; pinacidil completely reversed the BK-induced
depolarization with no effects on firing frequency of action
potential. (B) Summary data for A. n = 7, **p < 0.01.
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Page 6 of 12agonists, exert their antinociceptive effects, at least
partly, through activation of KATP [9]. In these studies,
the involvement of KATP was suggested from the fact
that the antinociceptive effects of these analgesic agents
could be inhibited by a KATP blocker. Thus, KATP activa-
tors are expected to show antinociceptive effects. How-
ever, conflicting results were obtained when KATP
activators were tested against different pain models.
Furthermore, even in the studies that did observe anti-
nociceptive effects, the effects were attributed to the
KATP-mediated activation of opioid receptors [9]. In
these studies, KATP activators were given via intracereb-
roventricular (i.c.v.), intrathecal (i.t.) or epidural injec-
tion. Thus, the direct effects of KATP on the excitability
500 pA
-20 mV
-50 mV
-20 mV
-60 mV
-140 mV
A
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Gly Gly
Cap
1 min
Gly Gly
Pin Cap Dia
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 control
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Figure 4 KATP opener activates glyburide-sensitive currents in DRG neurons. (A) Representative current traces recorded from a small
diameter DRG neuron using the voltage protocol shown at the top. Perforated whole-cell patch clamp was used. Effects of pinacidil (Pin) and
pinacidil (Pin) plus glyburide (Gly) were indicated. (B) The time course of currents recorded at -20 mV and -140 mV from a small diameter
neuron. Effects of KATP openers and blocker were indicated.
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Page 7 of 12of sensory neurons could not be determined from these
studies. A few studies have also observed the effects of
KATP activators on peripheral nociception. In these stu-
dies, KATP activators were tested against the hyperalgesia
caused by carrageenan or prostaglandin E(2) or in a for-
malin pain model. The activators reduced pain behavior
in these studies [31-33]. In the first part of our present
study, we studied the effects of two KATP activators,
pinacidil and diazoxide, on three different pain models,
and the results unequivocally demonstrate that
activation of KATP antagonizes the nocifensive behaviors
induced by bradykinin and thermal and mechanical nox-
ious stimuli. Bradykinin is a well-known inflammatory
mediator and one of the most potent endogenous pain-
inducing substances [35,36] .I no u re a r l i e rs t u d y ,w e
attributed BK-induced spontaneous pain to the inhibi-
tion of M channel K
+ currents and the activation of Ca
2
+-activated Cl
- currents in DRG neurons [20]. BK can
also induce hyperalgesia and allodynia [36,37], possibly
mediated by sensitization of TRPV1 [38] and TRPA1
A           
-200
-100
0
100
200
Gly
Pin Dia
Pin+Gly Dia+Gly
B
C
u
r
r
e
n
t
 
c
h
a
n
g
e
s
 
a
t
 
-
1
4
0
 
m
V
 
(
p
A
)
** **
300
control Pin Pin+Gly Dia Dia+Gly
0.0
0.2
0.4
0.6
0.8
1.0
1.2
 
*
N
o
r
m
a
l
i
z
e
d
 
c
u
r
r
e
n
t
 
(
a
t
 
-
1
4
0
 
m
V
)
Figure 5 KATP opener-activated currents in DRG neurons. (A) Effects of KATP openers and blocker on currents recorded at -140 mV from DRG
neurons. n = 12-20, the currents were normalized based on the control basal currents. (B) Absolute increased or reduced currents by KATP
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Page 8 of 12[39] through the activation of PKCε [40]. Activation of
M channels by the specific channel activator retigabine
antagonizes BK-induced pain behavior, indicating an
important role for M-type K
+ channels in the control of
sensory neuronal excitability [20]. On the other hand,
thermal and mechanical nociception are mediated by
TRPV channels [2,41-44]. Clearly these different noci-
ceptive stimuli employ different mechanisms for indu-
cing nociception, but they should all initiate the
nociceptive signals by increasing the excitability of noci-
ceptors. The non-discriminating effects of KATP activa-
tors in antagonizing the nocifensive behaviors induced
by different stimuli indicate the functional presence of
KATP in all the nociceptors mediating bradykinin-
induced and thermal and mechanical nociception. On
the other hand, the KATP blocker glyburide did not
affect any of the three nocifensive behaviors in the
absence of KATP a c t i v a t o r s .T h i ss u g g e s t st h a tK ATP
does not necessarily play a role in the nociception
induced by these stimuli, merely that the existence of
these channels provides a means of reducing hyperexcit-
ability when KATP activity is enhanced.
Effects of KATP activators on excitability of DRG neu-
rons are in agreement with the results from our nocifen-
sive behavioral study. Thus, pinacidil reversed the
hyperexcitability induced by BK in DRG neurons. In
addition, pinacidil also reversed the membrane depolari-
zation induced by BK. These effects of pinacidil are very
efficient and striking, and in all cases, the effects of BK
were completely reversed by pinacidil (Figure 2, 3 and
4). On the other hand, neither the KATP activators nor
the blocker per se affected the firing frequency or resting
membrane potentials of DRG neurons in the absence of
BK. Thus, as we observed in the nocifensive behavior
study, the effects of KATP c a no n l yb em a n i f e s t e dw h e n
nociception/DRG hyperexcitability/depolarization were
initiated by nociceptive stimuli. An increase in the
inward currents and/or a decrease in the outward cur-
rents is the first step in the activation of nociceptors,
which subsequently depolarizes the membrane and
increases the firing of APs. This scenario may provide a
setting for the manifestation of KATP function. As
demonstrated in a previous report, BK increases the
excitability of DRG neurons through the inhibition of
M-type currents and the activation of Ca
2+-activated Cl
-
currents [20]. M-type K
+ channels might be the domi-
nate contributor to the resting K
+ conductance [45] in
neurons, thus masking the contribution of other K
+
channels, such as KATP. The reduction of M-type K
+
currents would allow the function of other K
+ channels
to be unmasked. In addition, membrane depolarization
(Ca
2+ influx and inward currents through Cl
- currents)
would increase the driving force for outward KATP cur-
rents. The combination of these two changes could
explain the observed effects of KATP activators under
nociceptor activation. This possibility may not be lim-
ited to the explanation of KATP activators antagonizing
BK effects. In fact, with regard to the modulation of M-
type currents and membrane depolarization, other noci-
ceptive stimuli may result in same molecular environ-
ment as BK. The core of the BK mechanism is an
increase in intracellular Ca
2+ [20], which should be
shared by many other stimuli which activate TRPV
channels.
In the present study, KATP only induced small glybur-
ide-sensitive currents in a subpopulation of rat DRG
neurons. This modest effect of KATP activators indicates
that KATP function is not subject to modulation under
resting conditions. Furthermore, lack of significant
effects of glyburide on the basal currents of DRG neu-
rons further implies that KATP does not contribute sub-
stantially to the resting membrane conductance of DRG
neurons. This is in line with the observations from our
nocifensive and excitability experiments. A systematic
analysis of KATP distribution in subgroup DRG neurons
is lacking. Population of the small size DRG neurons are
believed to be the nociceptors. Clearly, these small DRG
neurons have functional KATP [15]. However, the activity
of the KATP in the small DRG neurons seems lower than
that of the KATP in the large DRG neurons, and further-
more, these KATP in two sizes of DRG neurons may
contributed differently to the development of the neu-
ronpathic pain [15]. The small nociceptive DRG neurons
are polymodal and are categorized into two major
classes based on peripheral and central target fields,
trophic factor dependence, and biochemical properties
[46]. These two classes of nociceptors, nonoverlapping
populations of trkA positive (tyrosine kinase A) peptid-
geric and isolectin-B4 (IB4) positive neurons may have
different mechanisms in controlling the excitability and
have different responsiveness to different stimuli. The
expression of KATP channels in peptidergic nociceptors
(CGRP positive) has been shown [17]. However, a sys-
tematic functional and expression study of KATP in
defined subpopulation of DRG neurons will help to
understand the role of the KATP in nociception further.
It seems that KATP-like currents can be readily
recorded at a single channel level from cell-attached or
isolated inside-out patches [13-15,17,20]. Although all
KATP channel subunits (Kir6.1 and Kir6.2) and SUR
receptors (SUR1 and SUR2) can be found in DRG neu-
rons at mRNA level, pharmacological, western blots and
immunohistochemistry studies suggest that the single
channel activity of KATP in DRG neuron may be the
results of heteromeric Kir6.2/SUR1 complex [17]. The
reports for whole-cell KATP-like currents in DRG neu-
rons are scarce; only two published papers have
reported KATP-like whole cell currents from DRG
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blocker-sensitive outwardly rectifying currents were
recorded [8]. This study also reported that the currents
conveyed by KATP account for only 10-25% of the total
potassium currents recorded [8]. In the present study,
we recorded a 10% increase over the basal currents in
response to KATP activators (Figure 5A). In another
report, the KATP activator diazoxide activated currents
in only a subpopulation of DRG neurons [11]. However,
the diazoxide-activated currents were not subjected to
testing for inhibition by a KATP blocker [11]. Further
experiments are needed to define the pharmacological
and biophysical properties of the whole-cell KATP-like
currents in DRG neurons. Taken together, our work
and that of other groups suggest that KATP is not a
dominant contributor to conductance under resting
conditions in DRG neurons.
In summary, our behavioral and electrophysiological
results support the notion that functional KATP channels
are present in nociceptors. KATP opening could antago-
nize the nociceptive responses evoked by noxious sti-
muli by dampening the hyperexcitability of the
nociceptors. On the other hand, KATP may not contri-
bute significantly to the resting membrane conductance
of the DRG neurons. Nevertheless, this should not dam-
pen enthusiasm for further investigation of KATP activa-
tors as potential candidates for antinociceptive
measures. In light of the findings that analgesic com-
pounds, such as morphine, may exert antinociceptive
effects through activation of KATP [16,27], direct activa-
tors of KATP, such as pinacidil and diazoxide, are cer-
tainly worthy of further investigation for their potential
analgesic actions. In this regard, our behavioral results
concerning these compounds provide a solid foundation
for future studies. The characteristics of molecular com-
positions, pharmacological modulation and biophysical
properties of the KATP in DRG neurons need to be
further investigated in order to find whether the KATP
in DRG neurons can be specifically modulated by the
channel activator to relieve the pain induced by different
stimuli.
Methods
Behavioral studies
Male Sprague-Dawley rats (180-220 g) were randomly
grouped and allowed to acclimatize for at least 20 min
to the environment prior to the experiment. Behavioral
studies were conducted in three separate experimental
settings: (1) Bradykinin-induced acute spontaneous pain.
The right hind paw of the animal received an intraplan-
tar injection (50 μl) of BK (200 μM, 10 nmol/site) or
solvent (saline) and the nocifensive responses (licking,
biting, lifting and flinching) were recorded using a video
camera for 30 min. The videos were analyzed by an
observer unaware of the treatment allocations. To study
the effects of activation of KATP channels on bradykinin-
induced nociceptive behavior, one group of animals was
pre-injected with the KATP activators. After 5 min, bra-
dykinin(BK) was co-injected with the activators into the
same site of the hind paw. Control animals were
injected with solvent (0.5% DMSO in saline) instead of
the KATP activators. In a second experimental group, the
KATP blocker was co-applied with the KATP activators.
Drugs were diluted in saline (pH 7.4) from stock solu-
tions (dissolved in DMSO) and applied at a volume of
50 μl at the following concentrations: diazoxide, 100
μM; pinacidil, 10 μM; glyburide, 10 μM. (2) Mechanical
withdrawal thresholds were measured using calibrated
von Frey filaments (a set of monofilaments made from
nylon filaments of varying diameter) (North Coast Medi-
cal, Inc. Morgan Hill, CA) applied to the plantar surface
of the paw. Testing was initiated with an Evaluator Size
5.07 (10 g). If the animal withdrew the paw, the next
weaker hair was applied. In the case of no withdrawal,
the next stronger hair was applied [47]. The cut-off was
Evaluator Size 6.10 (100 g). (3) To test for thermal
hyperalgesia, radiant heat was applied to the plantar sur-
face of a hind paw from underneath a glass floor using a
ray of light from a high-intensity lamp bulb. The paw
withdrawal latency was recorded automatically when the
paw was withdrawn from the light (TaiMeng Technol-
ogy Co., Ltd. Chengdu).
Rat DRG cell culture
The dorsal root ganglia were extracted from all spinal
levels of 32 adult male Sprague Dawley rats, and the
neurons were dissociated as previously described [20].
Briefly, the rats were anesthetized with an intraperito-
neal (i.p.) injection of pelltobarbitalum natricum (10-20
mg/kg) and then sacrificed. The ganglia were cut into
pieces, transferred into collagenase solution (1 mg/ml)
and incubated for 50 min at 37°C. The ganglia were
then placed into a trypsin solution (2.5 mg/ml) for 20
min at 37°C. The digested fragments were then rinsed
with 2 ml DMEM plus 10% fetal bovine serum three
times, centrifuged and dissociated by trituration. The
ganglia were plated onto glass coverslips pre-coated
with poly-D-lysine and incubated at 37°C. After the neu-
rons had attached to the coverslips, the cell culture
medium was changed to Neurobasal plus B27 supple-
ment (Invitrogen). Neurons were used within 24 h of
isolation. The diameter of the DRG neuron was mea-
sured using a calibrated micrometer mounted in the
eyepiece of the microscope.
Electrophysiology
Patch electrodes were pulled from borosilicate glass and
fire-polished to a final resistance of 1-2 MΩ when filled
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ments) patch clamp amplifier was used for voltage and
current clamp experiments. All recordings were per-
formed using the amphotericin B (250 μg/ml, Sigma)
perforated patch technique. The internal pipette solution
contained (in mM) 150 KCl, 5 MgCl2, 10 HEPES, pH
7.4. The external solution contained (in mM) 160 NaCl,
2.5 KCl, 5 CaCl2,1M g C l 2, 10 HEPES, and 8 glucose,
pH 7.4. A low-profile perfusion chamber fed by a gravity
perfusion system was used for solution exchange (2 ml/
min, bath exchange time of ~15 s).
Statistics
A l ld a t aa r eg i v e na sm e a n±S E M .D i f f e r e n c e sb e t w e e n
groups were assessed by Student’s t-test or one-way
ANOVA followed by Bonferroni’s post-hoc test. The dif-
ferences were considered significant at p ≤ 0.05.
Chemicals
Diazoxide; pinacidil; glyburide and capsaicin were
obtained from Sigma.
T h eu s eo fa n i m a l si nt h i ss t u d yw a sa p p r o v e db yt h e
Animal Care and Ethical Committee of Hebei Medical
University, (Shijiazhuang, China) under the IASP guide-
lines for animal use.
Additional material
Additional file 1: Fig S1. The anti-nociceptive effects of pinacidil
were not indirect results from the effects on targets other than
nociceptors. A, Pinacidil 10 μM was either injected contralaterally or
ipsilaterally with BK. BK (200 μM) was injected into the right hind paw of
the rats. For the contralateral injection, pinacidil was first injected into
the left hind paw of the rat, and 5 min later, pinacidil was again injected
in the left hind paw and at the same time, BK was injected into the right
hind paw of the rats. The nocifensive behavior (the time the animals
spent licking, biting and flinching the injected paw during 30 min) in the
right hind paw was counted. For the ipsilateral injection, pinacidil was
injected first into the right hind paw of the rats, and 5 min later,
pinacidil plus BK were injected in the right hind paw again. The
nocifensive behavior in the right hind paw was counted. B, Either
pinacidil or phentilamine (100 μM) was injected ipsilaterally with BK and
the nocifensive behavior was analyzed with the same protocol described
above and in the Methods. **p < 0.01, compared with the contralateral
(A), and compared with the control (B), n = 8-12.
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